SAN JOSE, Calif.--(BUSINESS WIRE)--Takara Bio USA Holdings, Inc. (“TBUSH”) today announced the acquisition of Curio Bioscience, a pioneering company in the field of spatial genomics.

Takara Bio USA is now accepting orders of the SmartChip ND Real-Time PCR System for shipment in Q4. Environmental surveillance laboratories have a critical need to monitor a wide range of targets at ...

Takara Bio Inc., together with its subsidiaries, engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...